Poxel S.A. (POXEL.PA)

EUR 0.43

(-1.38%)

Gross Profit Summary of Poxel S.A.

  • Poxel S.A.'s latest annual gross profit in 2023 was 1000.00 EUR , down -50.0% from previous year.
  • Poxel S.A.'s latest quarterly gross profit in 2023 FY was 1.98 Million EUR , up 98950.0% from previous quarter.
  • Poxel S.A. reported a annual gross profit of 2000.00 EUR in annual gross profit 2022, down -99.99% from previous year.
  • Poxel S.A. reported a annual gross profit of 13.33 Million EUR in annual gross profit 2021, up 113.24% from previous year.
  • Poxel S.A. reported a quarterly gross profit of 1001.00 EUR for 2023 Q4, down 0.0% from previous quarter.
  • Poxel S.A. reported a quarterly gross profit of -16.92 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Gross Profit Chart of Poxel S.A. (2023 - 2011)

Historical Annual Gross Profit of Poxel S.A. (2023 - 2011)

Year Gross Profit Gross Profit Growth
2023 1000.00 EUR -50.0%
2022 2000.00 EUR -99.99%
2021 13.33 Million EUR 113.24%
2020 6.25 Million EUR -76.45%
2019 26.55 Million EUR -64.4%
2018 74.6 Million EUR 1310.26%
2017 5.29 Million EUR 7428.85%
2016 70.26 Thousand EUR 103.89%
2015 34.46 Thousand EUR 248.47%
2014 -23.21 Thousand EUR -48.77%
2013 -15.6 Thousand EUR 0.0%
2012 - EUR 0.0%
2011 - EUR 0.0%

Peer Gross Profit Comparison of Poxel S.A.

Name Gross Profit Gross Profit Difference
ABIONYX Pharma SA 618 Thousand EUR 99.838%
ABIVAX Société Anonyme 3.91 Million EUR 99.974%
Adocia SA 1.38 Million EUR 99.928%
Aelis Farma SA 12.35 Million EUR 99.992%
Biophytis S.A. -803 Thousand EUR 100.125%
Advicenne S.A. 1.42 Million EUR 99.93%
genOway Société anonyme 20.1 Million EUR 99.995%
IntegraGen SA 5.01 Million EUR 99.98%
Medesis Pharma S.A. -2.66 Million EUR 100.038%
Neovacs S.A. 29.31 Thousand EUR 96.589%
NFL Biosciences SA -56.06 Thousand EUR 101.784%
Plant Advanced Technologies SA 2.15 Million EUR 99.954%
Quantum Genomics Société Anonyme -1.41 Million EUR 100.07%
Sensorion SA 3.78 Million EUR 99.974%
Theranexus Société Anonyme -4.63 Million EUR 100.022%
TME Pharma N.V. -127 Thousand EUR 100.787%
Valbiotis SA 2.66 Million EUR 99.963%
TheraVet SA -530.79 Thousand EUR 100.188%
Valerio Therapeutics Société anonyme 1.26 Million EUR 99.921%
DBV Technologies S.A. 4.15 Million EUR 99.976%
Genfit S.A. 28.22 Million EUR 99.996%
GeNeuro SA -293.8 Thousand EUR 100.34%
Innate Pharma S.A. -4.12 Million EUR 100.024%
Inventiva S.A. 17.5 Million EUR 99.994%
MaaT Pharma SA 1.65 Million EUR 99.94%
MedinCell S.A. 9.28 Million EUR 99.989%
Nanobiotix S.A. 36.2 Million EUR 99.997%
OSE Immunotherapeutics SA 2.22 Million EUR 99.955%
GenSight Biologics S.A. 3 Million EUR 99.967%
Transgene SA -28.4 Million EUR 100.004%
Valneva SE 52.83 Million EUR 99.998%